세계의 내시경 혈관 채취 시스템 시장 규모 : 제품 유형별, 사용성별, 혈관 유형별, 용도별, 지역 범위별 및 예측

Endoscopic Vessel Harvesting Systems Market Size And Forecast

Endoscopic Vessel Harvesting Systems Market size was valued at USD 480.28 Billion in 2024 and is projected to reach USD 642.28 Billion by 2032, growing at a CAGR of 3.70% during the forecast period 2026-2032.

Endoscopic Vessel Harvesting Systems Market Drivers

The market drivers for the Endoscopic Vessel Harvesting Systems Market can be influenced by various factors. These may include:

Growing Incidence of Cardiovascular disorders: Endoscopic vessel harvesting devices are becoming more and more popular worldwide, partly due to the growing prevalence of cardiovascular disorders. In order to treat coronary artery disease, coronary artery bypass graft (CABG) procedures depend heavily on these systems.

Improvements in Endoscopic methods: Endoscopic vascular harvesting is now safer, less intrusive, and more effective thanks to ongoing improvements in endoscopic methods and technologies. This promotes healthcare providers to use endoscopic vessel harvesting technologies.

Minimally Invasive Surgery: Because of its many advantages, including shorter hospital stays, quicker recovery periods, and fewer post-operative complications, minimally invasive surgical methods are becoming more and more popular among both patients and doctors. Endoscopic systems for harvesting vessels allow for less intrusive techniques in heart surgery.Population Aging: As people get older worldwide, there is a rise in the number of people who need heart surgery. Endoscopic vascular harvesting is one of the less invasive techniques that is especially beneficial for older patients because these patients frequently have comorbidities.

Healthcare Infrastructure expansion: The market for endoscopic vessel harvesting systems is expanding as a result of the expansion of healthcare infrastructure in emerging economies. There is more access to cutting-edge surgical methods and equipment as these areas develop their healthcare infrastructure.

Cost-Effectiveness: Endoscopic vessel harvesting devices can save money in the long run by lowering hospital stays, complication rates, and hastening patient recovery, even after they need an initial investment. One of the main reasons healthcare facilities want to invest in these systems is their cost-effectiveness.

Regulatory Support: By guaranteeing the safety and effectiveness of these devices, favorable regulatory regulations and approvals for endoscopic vessel harvesting systems across different areas foster market growth and increase healthcare providers' trust in implementing them.

Technological improvements: By drawing in medical professionals and patients who are looking for the newest methods in heart surgery, ongoing technological improvements targeted at enhancing the effectiveness, safety, and usability of endoscopic vascular harvesting devices propel market expansion.

Endoscopic Vessel Harvesting Systems Market Restraints

Several factors can act as restraints or challenges for the Endoscopic Vessel Harvesting Systems Market. These may include:

Expensive: Endoscopic vessel harvesting devices can be costly to operate, both initially and continuously. For smaller healthcare facilities or those with tighter funds, this can be a major obstacle.

Limited Reimbursement: Policies for reimbursement might not completely cover the expense of endoscopic vascular harvesting operations, which would discourage healthcare professionals from using them.

Technical Complexity: It may need specific training and expertise to become proficient in the methods needed for endoscopic vascular harvesting. As a result, there may be fewer medical personnel qualified to carry out these treatments.

Risk of problems: Endoscopic vascular harvesting carries the same risks of problems as any surgical surgery, including the possibility of bleeding, infection, and tissue injury. A few healthcare professionals might decide not to use these systems because of these hazards.

Opposition to Change: Surgeons may be reluctant to use new tools or methods, particularly if they have been successfully harvesting vessels using conventional methods for a long time.

Regulatory obstacles: Getting regulatory permission for novel endoscopic vessel harvesting devices can be a time-consuming and expensive procedure that might cause delays in entering the market or raise prices for producers.

Availability of Alternatives: Due to familiarity or perceived efficacy, certain surgeons or healthcare facilities may still favor traditional open vessel harvesting methods over endoscopic systems, which could hold down their adoption.

Patient Selection: Depending on the quality of the vessel, the anatomy of the patient, and any underlying medical issues, not every patient may be a good candidate for endoscopic vascular harvesting. As a result, the market for these systems is limited.

Infrastructure Requirements: Some healthcare facilities may not have the specialized equipment or operating rooms needed for endoscopic vessel harvesting systems, which could make them necessary.

Long-term Durability and Efficacy: Patients' and healthcare professionals' adoption rates may be impacted by doubts over the long-term durability and efficacy of endoscopic vessel harvesting in comparison to conventional techniques.

Endoscopic Vessel Harvesting Systems Market Segmentation Analysis

The Global Endoscopic Vessel Harvesting Systems Market is segmented on the basis of Product, Usability, Vessel-Type, Application, And Geography.

Endoscopic Vessel Harvesting Systems Market, By Product

• EVH Systems
• Endoscopes
• Accessories

Based on Product, The market is bifurcated into EVH Systems, Endoscopes, and Accessories. The EVH systems segment had the biggest market share, and it is predicted to grow at the fastest rate throughout the forecast period. This is due to the increasing use of less invasive techniques for vessel harvesting as well as the disposable nature of these products.

Endoscopic Vessel Harvesting Systems Market, By Usability

• Disposable
• Reusable

Based on Usability, The market is bifurcated into Disposable, and Reusable. The disposable segment accounted for the majority of the market. This category is also predicted to grow at the fastest rate over the forecast period, owing to a growing demand for disposable devices over reusable devices due to the benefits they offer.

Endoscopic Vessel Harvesting Systems Market, By Vessel-Type

• Saphenous Vein
• Radial Artery

Based on Vessel-Type, The market is bifurcated into Saphenous Vein and Radial Artery. During the forecast period, the saphenous vein segment is predicted to grow at the fastest rate. This is owing to the benefits of the saphenous vein in terms of wound complications, pain reduction, and aesthetics.

Endoscopic Vessel Harvesting Systems Market, By Application

• Coronary Artery Disease
• Peripheral Artery Disease

Based on Application, The market is bifurcated into Coronary Artery Disease and Peripheral Artery Disease. Because of the rising prevalence of cardiovascular illnesses and the growing geriatric population, the coronary artery disease sector is predicted to grow at the fastest rate throughout the forecast period.

Endoscopic Vessel Harvesting Systems Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world
• On the basis of Geography Analysis, The Global Endoscopic Vessel Harvesting Systems Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is now dominating the global market, followed by Europe because of the high incidence of coronary disease owing to sedentary lifestyle patterns adopted in these regions and the availability of all forms of minimally invasive CABG operations. Owing to the rise in per capita income in Asian countries and the growing medical tourism sector, the global market in the Asia Pacific is predicted to rise at a rapid pace.

Key Players

• The major players in the Endoscopic Vessel Harvesting Systems Market are:
• Bausch Health
• Sun Pharmaceutical Industries Ltd
• Novartis AG
• Teva Pharmaceutical Industries Ltd
• Roche
• Teva
• Abbott
• Johnson & Johnson
• Novo Nordisk
• Arena Pharmaceuticals
• Akrimax Pharmaceuticals.
• Sorin Group

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL ENDOSCOPIC VESSEL HARVESTING SYSTEMS MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL ENDOSCOPIC VESSEL HARVESTING SYSTEMS MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL ENDOSCOPIC VESSEL HARVESTING SYSTEMS MARKET, BY PRODUCT

• 5.1 Overview
• 5.2 EVH Systems
• 5.3 Endoscopes
• 5.4 Accessories

6 GLOBAL ENDOSCOPIC VESSEL HARVESTING SYSTEMS MARKET, BY USABILITY

• 6.1 Overview
• 6.2 Disposable
• 6.3 Reusable

7 GLOBAL ENDOSCOPIC VESSEL HARVESTING SYSTEMS MARKET, BY VESSEL-TYPE

• 7.1 Overview
• 7.2 Saphenous Vein
• 7.3 Radial Artery

8 GLOBAL ENDOSCOPIC VESSEL HARVESTING SYSTEMS MARKET, BY APPLICATION

• 8.1 Overview
• 8.2 Coronary Artery Disease
• 8.3 Peripheral Artery Disease

9 GLOBAL ENDOSCOPIC VESSEL HARVESTING SYSTEMS MARKET, BY GEOGRAPHY

• 9.1 Overview
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 U.K.
  • 9.3.3 France
  • 9.3.4 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Rest of Asia Pacific
• 9.5 Rest of the World
  • 9.5.1 Latin America
  • 9.5.2 Middle East & Africa

10 GLOBAL ENDOSCOPIC VESSEL HARVESTING SYSTEMS MARKET COMPETITIVE LANDSCAPE

• 10.1 Overview
• 10.2 Company Market Ranking
• 10.3 Key Development Strategies

11 COMPANY PROFILES

• 11.1 Getinge
  • 11.1.1 Overview
  • 11.1.2 Financial Performance
  • 11.1.3 Product Outlook
  • 11.1.4 Key Developments
• 11.2 MAQUET Holdings
  • 11.2.1 Overview
  • 11.2.2 Financial Performance
  • 11.2.3 Product Outlook
  • 11.2.4 Key Developments
• 11.3 Med Europe S.r.l.
  • 11.3.1 Overview
  • 11.3.2 Financial Performance
  • 11.3.3 Product Outlook
  • 11.3.4 Key Developments
• 11.4 Terumo
  • 11.4.1 Overview
  • 11.4.2 Financial Performance
  • 11.4.3 Product Outlook
  • 11.4.4 Key Developments
• 11.5 Saphena Medical
  • 11.5.1 Overview
  • 11.5.2 Financial Performance
  • 11.5.3 Product Outlook
  • 11.5.4 Key Developments
• 11.6 KARL STORZ
  • 11.6.1 Overview
  • 11.6.2 Financial Performance
  • 11.6.3 Product Outlook
  • 11.6.4 Key Developments
• 11.7 Cardio Medical
  • 11.7.1 Overview
  • 11.7.2 Financial Performance
  • 11.7.3 Product Outlook
  • 11.7.4 Key Developments
• 11.8 Medical Instruments Spa
  • 11.8.1 Overview
  • 11.8.2 Financial Performance
  • 11.8.3 Product Outlook
  • 11.8.4 Key Developments
• 11.9 LivaNova
  • 11.9.1 Overview
  • 11.9.2 Financial Performance
  • 11.9.3 Product Outlook
  • 11.9.4 Key Developments

12 Appendix

• 12.1 Related Research